T. Rowe Price Small-Cap Stock Fund, Inc.
T. ROWE PRICE SMALL-CAP STOCK FUND, INC. · 4 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
T. Rowe Price Small-Cap Stock Fund, Inc. is an actively managed U.S. equity fund.
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2026 Q1
The fund seeks to provide long-term capital growth by investing primarily in stocks of small companies.
The fund invests at least 80% of assets in stocks of small-cap companies, defined as those below the maximum market capitalization in the Russell 2000, MSCI USA Small Cap, or MSCI World Small Cap Index. The adviser selects stocks based on management quality, attractive business niches, pricing flexibility, sound financial practices, consistent revenue and earnings growth potential, and catalysts for price appreciation, applying either growth or value approaches. The fund may concentrate significantly in a single economic sector and may hold foreign stocks and recently public or privately held companies.
| Share class | Gross | Net | As of |
|---|---|---|---|
| OTCFX | 0.90% | 0.90% | 2025 Q1 |
| PASSX | 1.15% | 1.15% | 2025 Q1 |
| OTIIX | 0.77% | 0.77% | 2025 Q1 |
| TRZZX | 0.74% | 0.00% | 2025 Q1 |
Net is what a holder pays after the adviser's contractual waiver; gross is before it. A waiver can expire.
Portfolio turnover 78.10% · as of 2026 Q1
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 100.10% |
| Cash & short-term | 0.06% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Health Care | 19.0% |
| Industrials | 17.3% |
| Financials | 14.5% |
| Information Technology | 14.3% |
| 10 smaller | 34.9% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +28.03% | +52.19% | +23.94% | 12.61% | -14.52% | |
| +27.68% | +51.01% | +22.32% | 12.60% | -14.58% | |
| +28.19% | +52.78% | +24.78% | 12.60% | -14.50% | |
| +29.20% | +56.42% | +29.71% | 12.60% | -14.32% |
These classes hold the same portfolio, so the 7.39pp spread over 5 years is the cost difference between them — roughly 1.48pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Debt profile
What this fund holds — value-weighted across its bond and securitized long positions · as of 2026-06-30
Based on what filers reported; a filer that never reported a flag also reads as none.
Risk profile
Interest-rate and credit-spread sensitivity, both in years · as of 2026Q2
This fund filed the credit-spread disclosure and reported no sensitivity — measured, and the answer is none.
Show the numbers
| Tenor | Rate yrs | IG yrs | HY yrs | IG $/bp | HY $/bp |
|---|---|---|---|---|---|
| 3 mo | +0.00 | +0.00 | +0.00 | $0 | $0 |
| 1 yr | +0.00 | +0.00 | +0.00 | $0 | $0 |
| 5 yr | +0.00 | +0.00 | +0.00 | $0 | $0 |
| 10 yr | +0.00 | +0.00 | +0.00 | $0 | $0 |
| 30 yr | +0.00 | +0.00 | +0.00 | $0 | $0 |
Dollar change per 1bp of spread movement, as filed and sign-anchored. A blank cell was not filed; a zero was.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| LLYVK | LIBERTY LIVE HOLDINGS-CLLYVK | 2.54% | $105.64 | $236.19M | 2.2M |
| LSCC | LATTICE SEMICONDUCTOR CORPLSCC | 2.04% | $152.96 | $189.97M | 1.2M |
| VSEC | VSE CORPVSEC | 1.82% | $228.50 | $169.16M | 740.3K |
| DYN | DYNE THERAPEUTICS INCDYN | 1.67% | $22.21 | $155.57M | 7.0M |
| IMNM | IMMUNOME INCIMNM | 1.64% | $21.19 | $152.13M | 7.2M |
| LOAR | LOAR HOLDINGS INCLOAR | 1.47% | $80.61 | $136.68M | 1.7M |
| BTSG | BRIGHTSPRING HEALTH SERVICESBTSG | 1.34% | $69.74 | $124.74M | 1.8M |
| DNTH | DIANTHUS THERAPEUTICS INCDNTH | 1.21% | $97.48 | $112.64M | 1.2M |
| ESAB | ESAB CORPESAB | 1.14% | $98.63 | $105.53M | 1.1M |
| — | GOLAR LNG LTD | 1.13% | $49.84 | $104.76M | 2.1M |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 16.00% of net assets, top 25 30.40%, across 326 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free